Literature DB >> 19230600

Diclofenac and ketoprofen liver toxicity in rat.

Zdenko Tomic1, Boris Milijasevic, Ana Sabo, Lalosevic Dusan, Vida Jakovljevic, Momir Mikov, Satman Majda, Velibor Vasovic.   

Abstract

In the last years there appeared many articles about the adverse influence of non-steroidal anti-inflammatory drugs on the liver and heart. This study is concerned with the influence of the duration of treatment with diclofenac and ketoprofen on the macroscopic and microscopic changes in the liver, lungs, heart, and kidneys in rats. Experiments were carried out on mature Wistar strain rats. Animals of test groups received diclofenac and ketoprofen in a dose of 8 mg/kg/day (equivalent to the therapeutic dose for man) during 7 per os (p.o.) or 28 days intraperitoneally (i.p.), whereas controls received physiological solution p.o. A high morbidity was observed in the animals receiving diclofenac p.o. and somewhat lower in those treated with ketoprofen. On the other hand, the rats got through the 28-day i.p. treatment with both drugs mainly without significant complications. Macroscopic examinations revealed some changes in treated rats: distension of the stomach, ascites, fibrin deposits on the internal organs, lung effusion and the changes in color and structure of the liver. These changes were more frequent in the group of rats receiving diclofenac for the 7 days compared with those that received ketoprofen for the same time. It may be thought that the high mortality and macroscopic changes in the internal organs of experimental animals are a consequence of the microscopic changes in the liver and its lowered function.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19230600     DOI: 10.1007/BF03190881

Source DB:  PubMed          Journal:  Eur J Drug Metab Pharmacokinet        ISSN: 0378-7966            Impact factor:   2.441


  17 in total

1.  Pharmacokinetics and hepatotoxicity of diclofenac using an isolated perfused rat liver.

Authors:  G González-Martin; A R Domínguez; A Guevara
Journal:  Biomed Pharmacother       Date:  1997       Impact factor: 6.529

Review 2.  Preclinical and clinical development of dexketoprofen.

Authors:  D Mauleón; R Artigas; M L García; G Carganico
Journal:  Drugs       Date:  1996       Impact factor: 9.546

3.  The efficacy of buffered ketoprofen in postoperative pain after third molar surgery.

Authors:  R A Seymour; H Watkinson; J E Hawkesford; U Moore
Journal:  Eur J Clin Pharmacol       Date:  2000 Feb-Mar       Impact factor: 2.953

4.  Effects of long-term oral administration of ketoprofen in clinically healthy beagle dogs.

Authors:  Tatsuya Narita; Nobuyuki Tomizawa; Reeko Sato; Masanobu Goryo; Shigeo Hara
Journal:  J Vet Med Sci       Date:  2005-09       Impact factor: 1.267

5.  Comparison of the efficacy and safety of intravenously administered dexketoprofen trometamol and ketoprofen in the management of pain after orthopaedic surgery: A multicentre, double-blind, randomised, parallel-group clinical trial.

Authors:  H Zippel; A Wagenitz
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

6.  Pharmacokinetics of intravenous and rectal ketoprofen in young children.

Authors:  Hannu Kokki; Marko Karvinen; Pekka Suhonen
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

7.  Nonsteroidal antiinflammatory drugs in rheumatoid arthritis and osteoarthritis: support for the concept of "responders" and "nonresponders".

Authors:  J S Walker; R B Sheather-Reid; J J Carmody; J H Vial; R O Day
Journal:  Arthritis Rheum       Date:  1997-11

8.  Clinical pharmacokinetics of ketoprofen after single intravenous administration as a bolus or infusion.

Authors:  D Debruyne; B Hurault de Ligny; J P Ryckelynck; F Albessard; M Moulin
Journal:  Clin Pharmacokinet       Date:  1987-03       Impact factor: 6.447

9.  Pharmacokinetics and efficacy of low-dose ketoprofen in postoperative dental pain.

Authors:  R A Seymour; P J Kelly; J E Hawkesford
Journal:  Clin Drug Investig       Date:  1998       Impact factor: 2.859

Review 10.  Diclofenac sodium injection (Dyloject): in postoperative pain.

Authors:  Paul L McCormack; Lesley J Scott
Journal:  Drugs       Date:  2008       Impact factor: 9.546

View more
  4 in total

1.  Consumption of non-steroidal anti-inflammatory drugs in Serbia: a comparison with Croatia and Denmark during 2005-2008.

Authors:  Vesna Mijatović; Jelena Calasan; Olga Horvat; Ana Sabo; Zdenko Tomić; Vukašin Radulović
Journal:  Eur J Clin Pharmacol       Date:  2010-11-24       Impact factor: 2.953

2.  Effects of NSAIDs on the Release of Calcitonin Gene-Related Peptide and Prostaglandin E2 from Rat Trigeminal Ganglia.

Authors:  Vittorio Vellani; Giorgia Moschetti; Silvia Franchi; Chiara Giacomoni; Paola Sacerdote; Giada Amodeo
Journal:  Mediators Inflamm       Date:  2017-10-25       Impact factor: 4.711

3.  Controlled and tuneable drug release from electrospun fibers and a non-invasive approach for cytotoxicity testing.

Authors:  G Piccirillo; D A Carvajal Berrio; A Laurita; A Pepe; B Bochicchio; K Schenke-Layland; S Hinderer
Journal:  Sci Rep       Date:  2019-03-05       Impact factor: 4.379

4.  Gallic acid mitigates diclofenac-induced liver toxicity by modulating oxidative stress and suppressing IL-1β gene expression in male rats.

Authors:  Mohsen Esmaeilzadeh; Esfandiar Heidarian; Mehrnoosh Shaghaghi; Hoshang Roshanmehr; Mohammad Najafi; Alireza Moradi; Ali Nouri
Journal:  Pharm Biol       Date:  2020-12       Impact factor: 3.503

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.